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STUDY PROTOCOL

Open Access

Protocol for a feasibility study of groupbased focused psychosocial support to
improve the psychosocial well-being and
functioning of adults affected by
humanitarian crises in Nepal: Group
Problem Management Plus (PM+)
Manaswi Sangraula1*, Edith van’t Hof2, Nagendra P. Luitel1, Elizabeth L. Turner3, Kedar Marahatta4,
Jolene H. Nakao5,6, Mark van Ommeren2, Mark J. D. Jordans1,7 and Brandon A. Kohrt1,8

Abstract
Background: The prevalence of common mental disorders increases in humanitarian emergencies while access to
services to address them decreases. Problem Management Plus (PM+) is a brief five-session trans-diagnostic
psychological WHO intervention employing empirically supported strategies that can be delivered by non-specialist
lay-providers under specialist supervision to adults impaired by distress. Two recent randomized controlled trials in
Pakistan and Kenya demonstrated the efficacy of individually delivered PM+. To make PM+ more scalable and
acceptable in different contexts, it is important to develop a group version as well, with 6–8 participants in session.
A study is needed to demonstrate the feasibility and acceptability of both the intervention in a new cultural
context and the procedures to evaluate Group PM+ in a cluster randomized controlled trial.
Methods: This protocol describes a feasibility trial to Group PM+ in Sindhuli, Nepal. This study will evaluate
procedures for a cluster randomized controlled trial (c-RCT) with Village Development Committees (VDCs), which
are the second smallest unit of government administration, as the unit of randomization. Adults with high levels of
psychological distress and functional impairment will receive either Group PM+ (n = 60) or enhanced usual care
(EUC; n = 60). Psychological distress, functional impairment, depression symptoms, posttraumatic stress disorder
(PTSD) symptoms, and perceived problems will be measured during screening, pre-treatment baseline, and 7–
10 days after the intervention. Qualitative data will be collected from beneficiaries, their families, local stakeholders,
and staff to support quantitative data and to identify themes reporting that those involved and/or effected by
Group PM+ perceived it as being acceptable, feasible, and useful. The primary objective of this trial is to evaluate
the acceptability and feasibility of the intervention; to identify issues around implementation of local adaptation
methods, training, supervision, and outcomes measures; and to assure that procedures are adequate for a
subsequent effectiveness c-RCT.
(Continued on next page)
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Discussion: Outcomes from this trial will contribute to optimizing feasibility and acceptability through cultural
adaptation and contextualization of the intervention as well as refining the design for a c-RCT, which will evaluate
the effectiveness of Group PM+ in Nepal.
Trial registration: ClinicalTrials.gov identifier: NCT03359486
Keywords: Low- and middle-income countries, Mental health, Non-specialists, Group interventions, Humanitarian
emergencies

Background
Humanitarian crises, such as the earthquake in Nepal in
April 2015, cause significant psychological and social suffering. Nepal’s fragmented and under-resourced mental
health and social services are not able to cope with such a
high level of need [1]. The country has 0.22 psychiatrists
and 0.06 psychologists per 100,000 people, mainly working in large cities [1]. Nepal has basic health care units
with primary care staff and midwives, and in most districts, there are other community care providers, often
working for NGOs. The availability of this system makes a
model of care provision through non-specialists a particularly important implementation strategy.
In low-resource settings, mental health interventions
may need to be short of duration and carried out by
non-specialists in the communities to make them sustainable and feasible to implement on a broader scale. A simplified psychological intervention, Problem Management
Plus (PM+), has been developed by the World Health
Organization (WHO) to address this. It has four core features that make the intervention suitable for low-resource
settings exposed to adversities: a brief intervention (five
sessions) (1) delivered individually or in groups; (2) delivered by non-specialists (high school graduates with no
mental health experience), using the principle of task
shifting; (3) designed as a trans-diagnostic intervention,
addressing a range of client-identified emotional (e.g., depression, anxiety, stress) and practical problems; and (4)
designed for people in communities in low- and
middle-income countries (LMIC) affected by any kind of
adversity (e.g., violence, disasters) [2].
Recent randomized controlled trials (RCTs) in Peshawar
(Pakistan) and Nairobi (Kenya) have indicated individually
delivered PM+ to be effective in diminishing depression
and anxiety symptoms, managing self-selected practical or
psychological problems, and improving daily functioning
[3, 4]. The first evaluation of a Group PM+ is underway in
Pakistan [4]. This paper describes the study protocol of a
feasibility trial with Group PM+ in Nepal before evaluating
effectiveness in a fully powered cluster RCT (c-RCT) [5].
Feasibility studies are valuable to address issues related to
process, resources, management, or scientific approaches
[6, 7] in so the issues can be addressed before conducting
definitive randomized trials.

Objectives

For Group PM+ in Nepal, we will implement trial procedures to gather information about feasibility, acceptability, safety, and delivery of the intervention in a Nepali
community setting, and to assess training, supervision,
and outcomes measures. The Group PM+ manual has
been adapted for post-earthquake rural Nepal through
qualitative formative research (has not been published).
The feasibility trial will further identify whether the clinical and content adaptations are appropriate for the setting. Possible problems of acceptability, compliance,
delivery of the intervention, randomization, blinding, recruitment, and retention will be assessed before the effectiveness c-RCT is conducted [7]. The feasibility study
will include two trial arms: enhanced usual care (EUC)
and Group PM+. We will assess the acceptability and
feasibility of the Group PM+ intervention compared to
EUC and will collect data for the design of a full-scale
effectiveness c-RCT of Group PM+ compared to EUC.
We will use a mixed-methods design with qualitative
and quantitative approaches to determine feasibility. The
objectives include the following:
1. To evaluate the feasibility and acceptability of the
Group PM+ intervention in a rural Nepal
community [primary objective];
2. To evaluate the feasibility and acceptability of
intervention delivery by Group PM+ trained nonspecialists;
3. To determine recruitment and retention rates for
Group PM+ sessions;
4. To assess feasibility and acceptability of outcome
measures;
5. To assess feasibility of cluster randomization
procedure to limit biases and risk of contamination;
6. To assess ethics and safety of trial procedures using
the adverse event protocol.

Methods/Design
Setting

Nepal is a low-income country in South Asia with a
population of approximately 27 million with the majority
(83%) of the population living in rural areas [8]. The
country suffered a decade-long civil war from 1996 to
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2006 with a range of psychiatric sequelae among adults
and children [9–11]. In 2015, there were two major
earthquakes in 2015, killing approximately 10,000 people
and injuring 20,000. A mental health epidemiological
study in Sindhupalchowk, Gorkha, and Kathmandu conducted 3 months post-earthquake found that one in
three adults were experiencing depression and anxiety,
one in five adults engaged in harmful alcohol use, and
one in ten adults had current suicidality [12]. The compromised infrastructure and limited availability of specialized mental health services is an impediment to
addressing this burden of mental health problems.
The study will take place in Sindhuli district, a region
southeast of Kathmandu, which was heavily impacted by
the earthquakes. In Sindhuli, 250 people were injured
and 15 were killed. Over 22,000 households were fully
damaged and 10,000 partially damaged. In response to
the earthquake’s effects on Sindhuli, Transcultural Psychosocial Organization (TPO) Nepal in collaboration
with International Medical Corps (IMC) conducted
mental health and psychosocial support (MHPSS) activities in over half of the district’s Village Development
Committee (VDCs) from 2015 to 2017. TPO Nepal is a
Nepali non-governmental mental health research and
training organization, with specific expertise in humanitarian settings [13]. For the Group PM+ feasibility study,
two Village Development Committees (VDCs) that had
not previously received services were selected for
randomization to either EUC or the intervention. Approximately 5000 people live in each VDC.
The selected VDCs have a diverse population with
over 15 ethnicities, including Brahman/Chhetri, Magar,
Tamang, and Dunwar. The national language Nepali is
spoken by the majority of inhabitants. A formative qualitative study in these VDCs demonstrated that residents
of these VDCs have minimal access to and awareness of
mental health issues and its treatment. Each VDC has
one government health post, which represents the first
and most accessible portal of care, though often not the
well-resourced. Primary healthcare workers in these facilities include health assistants, community medical assistants, auxiliary nurse midwives, and female
community health volunteers (FCHVs).
Design

Randomization will occur at the VDC level, and one
VDC will receive the intervention while the other will
receive EUC. Though not identical, the two VDCs are
similar in population size, ethnic demographics, and access to health facilities. The two VDCs will be randomized in a public drawing by the District Public Health
Officer (additional details provided below in the
Randomization procedure). The two VDCs are separated
by an adjoining VDC in attempt to limit intervention
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contamination among the beneficiary populations. Because there are two units of analysis for this trial, adjustment for clustering will be considered for analyzing the
effectiveness of the definitive trial.
Intervention: EUC versus Group PM+ intervention

Until recently, treatment-as-usual in rural Nepal for individuals with common mental disorders (CMD) in
Nepal usually consists of no psychological/psychiatric
treatment in local health facilities. Whereas experiencing
a CMD rarely leads to treatment initiation, persons with
severe mental illnesses are typically brought by family
members to tertiary psychiatric services in the
Kathmandu valley, and this is often after a long delay between onset of symptoms [1]. Beginning in 2012, the
WHO mental health Gap Action Programme (mhGAP)
Intervention Guide was adapted for use in Nepal and
piloted in Chitwan district through the Programme for
Improving Mental Health Care (PRIME) [14]. After the
2015 earthquakes, the mhGAP Humanitarian Intervention Guide [15] was adapted and contextualized for
Nepal, and Nepali psychiatrists were taught to train primary care workers using mhGAP. This approach was
used in Sindhuli. Therefore, the EUC arm in Nepal will
receive a referral to primary care-based depression
treatment.
Participants in the Group PM+ arm will receive five
3-h sessions of Group PM+. Each session focuses on
teaching participants’ techniques to manage their
stressors and problems. These sessions include (1) managing stress, (2) behavioral activation, (3) managing
problems, (4) strengthening social support, and (5) review of techniques [16]. See Table 1 for more details on
each session.
There will be a total of 60 participants in each arm. In
the intervention arm, there will be approximately 7–10
groups with six to eight participants per group, separated by gender and with gender-matched facilitators.
Facilitators will be supported by volunteer helpers in organizing the logistics of the group sessions, reminding
participants about the sessions, and meeting
non-attenders (participants who do not show up for
Group PM+ sessions). Participants will be provided with
calendars and reminder calls by the facilitators’ helpers,
if necessary, to decrease dropout rates.
To conduct awareness-raising activities and facilitate
recruitment, five non-specialists will be recruited in the
EUC arm and another five in the Group PM+ arm. The
requirement for the non-specialists will be at least
10 years of education, over 25 years of age, and living in
either the EUC or Group PM+ VDC. The
non-specialists will be trained by TPO Nepal for 20 days
on basic psychological skills to become community psychosocial workers (CPSWs). Twenty days is the standard
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Table 1 Mechanisms of action of Group PM+ intervention
PM+
mechanisms
of action

Description of mechanism

Implementation
of mechanism

Stress
management

Participants learn deep breathing.
They are encouraged to incorporate
this mechanism into daily life (i.e.,
when doing housework, walking,
etc.). Grounding techniques are
incorporated to bring participants
back to the present.

Session 1

Behavioral
activation

Participants review the inactivity
Session 2
cycle. They choose a small activity
that they enjoy doing (i.e., making
and drinking tea, meeting a friend,
etc.) and create a detailed plan
about when and how to conduct
this activity as a first step in breaking
the inactivity cycle.

Managing
problems

Participants learn which of their
Session 3
problems are solvable and which are
unsolvable. One problem is chosen
among the solvable problems, and
participants brainstorm tangible
solutions, then creating manageable
steps to accomplish their goals.

Strengthening
social support

Participants learn to recognize who
among their family and friends are
existing and potential sources of
support and how best to strengthen
connections with them. Social
network mapping activities are
incorporated in this mechanism.

Session 4

Note: The first four sessions of PM+ each addresses a specific mechanism of
action. The fifth and last session is a review of the mechanisms of actions
learned in the previous sessions

length for CPSW training through TPO Nepal, based on
the expectation that briefer training would not equip facilitators to provide quality care to intervention participants. CPSWs from the intervention arm will then be
given a 10-day Group PM+ training using the adapted
manual and other clinical materials. Intervention training includes education on adversity and its impact upon
mental health, basic counseling skills, delivering Group
PM+, skills in group facilitation, and facilitator self-care.
Group “Helpers” will receive a basic 2-day training on
assisting facilitators during Group PM+ sessions and
participating alongside CPSWs in practice PM+ groups.
The main role of helpers will be logistics and child care.
Competency and fidelity will be assessed with modified
version of the Enhancing Assessment of Common
Therapeutic Factors (ENACT) tool tailored for Group
PM+ [17].
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quantitative and qualitative indicators will clarify what
procedures to carry on to the full trial and where modifications should be made to study design or content [18].
The following quantitative indicators will determine progression to the main trial:
(a) Fidelity to Group PM+ elements at the level of 75%
or greater according to the mean fidelity checklist
for Group PM+ elements across all sessions;
(b) Lack of significant socio-demographic group differences; tabulation of descriptive summaries for
baseline characteristics comparing Group PM+
participants and EUC participants without
significant group differences in education, economic
status, age, gender, and medical comorbidities;
(c) Retention of at least 67% of participants through
completion of five Group PM+ sessions;
(d) Fewer than 15% missing items on outcome
measures across all assessments;
(e) Presence of adverse events among fewer than 10% of
participants and any serious adverse events;
The following qualitative indicators will determine
progression to the main trial:
(a) Identification of qualitative themes reporting that
both CPSWs and beneficiaries perceive Group PM+
as being acceptable, feasible, and useful; the
qualitative data will be coded for themes that
participation reduces psychological distress, that
participation does not damage familial or
community relations, that participation is perceived
as safe, and that participation is not perceived as
stressful resulting in worsening mental health (see
Table 2);
Feasibility and acceptability will be evaluated by these
indicators to determine progression to the full trial. In
domains where criteria are met, we will retain the procedure for the full trial. In domains where criteria are
not met, we will modify procedures for the full trial. The
presence of any adverse events and serious adverse
events will be addressed by the trial team to identify alternative strategies for the full trial and Data Safety
Monitoring Committee, which is described in detail
below. The number of feasibility and acceptability criteria that are not met will determine the extent of intervention and trial design modification.

Feasibility criteria

The primary objective is to evaluate feasibility and acceptability of both the intervention and the trial procedures for the subsequent c-RCT through the collection
of both quantitative and qualitative data [4]. Because
feasibility and acceptability are complex domains, both

Measures/outcomes

Because the primary objective of this trial is to evaluate
feasibility and acceptability, we will assess whether the
established feasibility criteria were met. To support the
five quantitative criteria listed above, qualitative data will
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Table 2 Qualitative domains and objectives

Table 2 Qualitative domains and objectives (Continued)

Domains

Participants interviewed

Sample research
questions

1. Acceptability of Group
PM+

Participants, family,
CPSWs, community,
psychosocial team

Is PM+ stigmatizing? Is it
acceptable for CPSW to
deliver PM+? What were
parts of the program that
could have been
changed to make the
program more acceptable
for the community?

2. Implementation
logistics; PM+ sites, local
leadership

CPSWs, community, RAs
and research staff,
psychosocial team
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How would we enhance
project implementation
(in terms of venue,
coordination with local
leadership, etc.)?

3. Feasibility of PM+ and
Participants, family,
burden (time, frequency,
CPSWs, community,
distance for providers and psychosocial team
participants)

How would make this
program more
sustainable? How would
make this program more
effective? Should the
program be longer?

4. Fidelity and supervision
(areas of deviation and
cause, competency,
amount and form of
supervision)

CPSWs, psychosocial
team

How did the CPSWs
deviate from the material
in the PM+ manual? Why
did they deviate from the
material? Was there a
need for more or less
supervision? What were
the challenges to
supervision?

5. Utility (perceived
benefit) of PM+

Participants, family,
CPSWs, community,
psychosocial team

How do CPSWs perceive
participant experience?
What problems is PM+
helpful for? What
problems is PM+ not
helpful for? Who is PM+
useful for?

6. Contagion

Participants (control
group), family, CPSWs,
RAs and research staff,
psychosocial team

Did anyone involved in
PM+ teach friends, family,
and community members
PM+ techniques? Did the
mechanisms of action for
PM+ reach the control
VDC? If so, how did those
in the control group
learn?

7. Blinding/randomization; CPSWs, mhGAP,
sources and timing of
community, RAs and
unbinding
research staff,
psychosocial team

When did RAs and CPSWs
know that different
groups received different
treatment? How did they
know about the different
groups?

8. Recruitment and
retention (participants
and providers)

Participants, family,
CPSWs, community, RAs
and research staff,
psychosocial team

What were challenges to
recruitment? What were
challenges to retention of
participants in the
program? What are
possible solutions to
recruitment and
retention?

9. Adverse events, ethics,
safety

Participants, family,
CPSWs, mhGAP, RAs and
research staff,
psychosocial team

Were staff equipped to
handle any adverse
events? What was the
type and
fBMW80481requency of
adverse events referred?

10. Referral and control
condition

Participants, family,
CPSWs, mhGAP,
community, psychosocial
team

Were mhGAP services
available? Was medication
available in local health
posts? Was the TPO
counselor used by the
community? Was

Domains

Participants interviewed

Sample research
questions
transportation to local
referrals available to those
who needed it?

11. Assessment feasibility,
acceptability,
interpretation

Participants, RAs and
research staff, CPSW

Were the assessments
feasible to conduct? Did
the participants
understand the
assessments? What were
the challenges to
conducting assessments?

be collected from beneficiaries, their families, local
stakeholders, and staff to identify qualitative themes
reporting that those involved and/or effected by Group
PM+ perceived it as being acceptable, feasible, and useful. Qualitative interviews will be conducted throughout
the trial (see Table 3).
Though the clinical outcomes in this feasibility and acceptability trial are secondary, the ability to measure them
and have fewer than 15% missing items is a feasibility outcome. Clinical outcomes among participants will be measured through baseline (t0) and follow-up (t1) assessment.
The baseline (t0) assessment will be conducted after the
family meeting. The follow-up assessment (t1) will be
scheduled 1–1.5 weeks after the fifth Group PM+ session
(i.e., 8–8.5 weeks after the pre-intervention assessment).
All instruments will be administered by trained research
staff blind to the allocation status of the participants. The
main analysis metric will be differences in primary and
secondary outcomes between t0 and t1.
The primary clinical outcome measure will be the Patient Health Questionnaire (PHQ-9), a well-known
10-item instrument measuring symptoms of depression
[19] (see Table 3). The measure has been clinically validated in Nepal [20]. There are eight secondary clinical
outcome measures. To diminish the burden of time and
questionnaires administered to the participants, many
short-form versions of the assessments will be used. The
WHO Disability Assessment Scale (WHODAS) has been
used previously in Nepal [21–23], with excellent internal
consistency between items (α = 0.90) and validity with
multiple mental health measures for depression (r = 0.70,
p < 0.001), anxiety (r = 0.64, p < 0.001), and PTSD (r =
0.37, p < 0.001). The GHQ-12 measures general psychological distress and has been clinically validated in Nepal
[24]. The Psychosocial Mental Health Problems (PMHP)
scale is a locally developed five-item assessment of common psychosocial problems [10]. The heart-mind
screener is also locally developed and will be used to determine the acceptability of local idioms of distress and
impairment due to these problems [20]. The PCL-5
(eight items) was shown in a recent study to have comparable diagnostic utility to the 20-item PCL-5 [25].
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Table 3 Qualitative interview schedule
Stakeholder

Definition

Beneficiaries/ Intervention (n = 10):
clients
participants who attended
sessions regularly, those who
dropped out sessions, those
who improved in clinical
outcomes at their follow-up
assessment, those who did
not improve in their clinical
outcomes at follow-up, and
at least one male from each
of these sub-groups
Control (n = 5): participants
who improved in clinical
outcomes at their follow-up
assessment, those who did
not improve in their clinical
outcomes at follow-up, and
at least one male from each
of these sub-groups

Type of
interview

When

Key
Informant
Interviews
(KIIs)

After sessions of PM
+
(Rolling)

Psychological Outcomes Profiles instrument [28] will be
administered pre- and post-intervention as well as from
sessions two to five for the PM+ intervention arm. The
PSCYHLOPS will not be administered during session
one of PM+ because of the proximity in time between
pre-intervention and start of the sessions.
Randomization

Family

Intervention (n = 5): family
KIIs
members of participants who
dropped out of sessions,
family members of
participants who did not (and
did not) improve in their
clinical outcomes at followup, and at least one male
participant’s family from each
sub-group
Control (n = 3): family
members of participants who
did not (and did not)
improve in their clinical
outcomes at follow-up and at
least one male participant’s
family from each sub-group

5 weeks after family
meeting (Rolling)

CPSWs and
helpers

Intervention (n = 4): CPSWs
that facilitated sessions and
helpers that assisted CPSWs
in these sessions
Control (n = 4): CPSWs

After each session
of PM+ training,
during sessions,
post-intervention

MhGap
providers

Intervention and control (n = KIIs
2): Health workers in the local
health posts that received
training in mhGap

After completion of
intervention

Community
Leaders

Intervention and control (n =
8): Community leaders
(including members of
mothers’ groups, local
government officials,
traditional healers, etc.) who
received CIDT training as a
part of recruitment efforts

KIIs

After completion of
intervention

RAs and
Intervention and control (n =
research staff 8): RAs and Research
Supervisor

KIIs, FGDs

After completion of
intervention

Psychosocial
staff

KIIs, FGDs

Intervention and control (n =
3): Clinical Supervisors and
counselor
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KIIs, Focus
Group
Discussions
(FGDs)

Two VDCs will be selected within Sindhuli district for
the control and intervention arms (see Fig. 1). A meeting
will be organized with the District Public Health Officer
(DPHO) where VDCs will be randomly drawn for either
of the trial arms. We chose to involve the DPHO in the
randomization process to increase community engagement and governmental support for the research trial.
The DPHO will conduct a drawing open to government
staff and supervisors in the research team. CPSWs and
RAs will not be present for this drawing. The DPHO will
draw one of the two names out of a hat. There are several sources of potential contamination. CPSWs from
both VDCs will be trained together for the initial 20-day
community psychosocial training. Because of the proximity between the two VDCs, communities may be in
contact with one another. CPSWs and RAs will be given
a strict code of conduct to keep patient treatment confidential during the trial to reduce unblinding. Regardless,
sources of potential contagions will be monitored closely
and addressed in the full-scale trial after completion of
the feasibility trial.
Participants

After completion of
intervention

The Multidimensional Scale of Perceived Social Support (MSPSS) has been locally adapted in Nepal during a
study among widows [26] and has been modified to for
this trial. In the assessment, participants will assess their
own connectedness with close family, friends, and other
forms of support. The Reduced Tension Checklist (RTC)
has been locally developed based on a coping checklist
[27] to assess skill acquisition of PM+ skills. The

Residents of the two VDCs 18 years of age and older are
eligible for enrollment. There is no maximum age for
the enrollment. However, assessors will use their discretion to discontinue screening for those that are unable
to properly comprehend the questions due to age or are
unable to physically reach session locations within the
VDC.
Inclusion criteria

Adults potentially with a common mental disorder are
eligible to participate when they are over 18 years old
and speak and understand Nepali. The General Health
Questionnaire (GHQ; see below) and the WHO Disability Assessment Schedule 2.0 will be used for the screening criteria. Screening positive is defined as positive on
all the following: score > 2 on a screening questionnaire
for common mental disorders [29, 30] and score > 16 on
a screening questionnaire for functional impairments
[31]. Because of the lack of other services and potential
benefit from participation in Group PM+, individuals
with suicidality are not excluded. However, persons with
current suicidal plans will be referred to the TPO
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a mhGAP-trained health professional in the area. In case
of any suspected severe psychiatric disorders (e.g., psychosis) or problems (e.g., active suicidality), the individual
will be referred to the health facility where health
workers have been trained in mental health treatment
(following mhGAP) and/or the TPO counselor in the
area. For urgent treatment (e.g., active suicidality), participants will be immediately referred to the local TPO
counselor and/or the nearest psychiatric services, which
are available in a hospital 7 h drive from the study site.
A TPO Nepal counselor and clinical supervisor for the
trial will also be available to facilitate the referral process
and provide follow-up psychosocial care, if and when
needed. Symptoms of psychosis and severe cognitive impairment are based on clinical judgment of the assessor.
The assessor (research assistant) will be given training
on a community case-finding tool for detection of
psychosis [33], so they can better understand clinical
symptoms for exclusion (see more details below on the
community case detection tool in the “Recruitment” section). If the respondent is not able to comprehend or answer the consent and/or demographic questions
coherently, the questionnaire will be terminated at that
point.
In addition to collecting trial outcomes, we will conduct a qualitative component. We will conduct key informant interviews (KII) and focus group discussion
(FGD) and collect process notes. For the qualitative
component, we will select a subsample of intervention
and control arm participants for KIIs and focus group
discussions. In addition, we will conduct KIIs with
CPSWs, family members of the participants, research
staff, community officials, and primary health care staff.
Fig. 1 Flowchart for Group PM+ cluster randomized controlled trial.
Flow diagram from recruitment to end line assessment for
participants/respondents in control and intervention VDCs. Gray box
represents intervention. Abbreviations: CIDT, Community Informant
Detection Tool (see the “Recruitment” section). VDC, Village
Development Committee

counselor in addition to the invitation to participate in
Group PM+.
Exclusion criteria

Alcohol dependency will be assessed by the alcohol use
disorders identification test (AUDIT). Persons with a
score of 16 and higher will be excluded from participation. WHO’s guidelines for use in primary care report
that people that score below 16 can benefit from simple
advice [32] and also stated that people who score 16 and
higher would benefit most from simple advice plus brief
counseling and continued monitoring. For this reason,
potential participants who score 16 and above on the
AUDIT will be excluded from the study and referred to

Recruitment

In the study VDCs, CPSWs will conduct
awareness-raising activities to educate the public about
availability of treatment for CMDs. In addition, female
community health volunteers (FCHVs) and members of
local community organizations (such as mothers’ groups,
youth groups, etc.) will be trained on the Community
Informant Detection Tool (CIDT) to identify people in
the community with potential common mental disorders. The CIDT is a vignette-based tool for pro-active
case detection by lay people, which has been developed
and tested in Nepal [34]. The CIDT has a positive predictive value of 0.68 for adults [33]. The adapted version
of CIDT for this study will include both inclusion vignettes (e.g., general distress, developed for the trial) and
exclusion vignettes (e.g., psychosis, which have already
been developed and validated). When community members and FCHVs identify a person in the community
with symptoms of common mental disorders as described in the vignettes, they will ask them if they would
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like support for their stress-related problems. If people
indicate they would like to receive support, then they
will be told that a research assistant (RA) will visit them
to conduct further screening. Individuals who meet
CIDT criteria for exclusion conditions will be referred to
local mhGAP-trained health workers. RAs will conduct
additional recruitment by screening patients attending
primary health care centers.
After screening by the RAs, CPSWs will hold a family
meeting with the potential participant and a family
member if they choose to have a family member participate. The family meeting will consist of (a) information
about the results of the screening, (b) brief psychoeducation about the psychological consequences of adversity,
and (c) information on seeking services from local health
facilities with health care providers trained in basic mental health and psychosocial support. Those in the Group
PM+ arm will also receive information about the intervention. Based on the family meeting, individuals can
choose whether or not they want to enroll in their respective treatment arms and continue in the study.
Blinding and concealment

CPSWs,
RAs,
trial
participants,
and
local
mhGAP-trained health workers will be blinded to the
conditions of the two arms. Facilitators in the intervention arm and CPSWs in EUC will be instructed not to
disclose the treatment that any participants are receiving
except with their clinical supervisors. Assessors will be
asked at baseline to indicate what treatment they think
each participant will receive. Assessors will be asked the
same question at end line for each participant. This will
provide some data on the amount of unblinding that
might occur in the RCT. Study statisticians will be
blinded to treatment arm during analysis.
Sample size

Approximately 60 participants will be enrolled in each
treatment arm through pro-active case-finding methods.
Approximately 60 participants were enrolled for each
arm in a previous Group PM+ feasibility trial [5]. Because power calculations will not be carried out for this
trial, 60 participants, or 7–10 groups, per arm will provide enough relevant information to inform feasibility
and acceptability for the definitive effectiveness RCT following the trial. In addition, approximately 15 trial participants will be recruited for the qualitative interviews,
as well as 15–18 additional key informants from the
community. We also anticipate conducting qualitative
interviews with research and psychosocial staff.
Financial incentives

Participants will receive compensation in the form of
household goods (e.g., soap, toothpaste) equivalent to
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100–200 Nepali Rupees per assessment, to compensate
for time invested in the research. Assessments will take
a maximum of 1 h and 30 min, and participants will be
informed of this time frame as part of the consent
process. Participants will not be compensated monetarily
for the time they spend in the sessions. For those in the
treatment arm, snacks and tea will be offered to the participants at every session. Travel costs to sessions and to
assessments will be compensated for as well. Actual cost
basis is not currently feasible because of the unavailability of local transport receipts but a fixed amount for
compensation will be calculated based on the area that
they come from.
Data management and monitoring

All principal investigators (PI) on the study will have access to primary data. The site PI will conduct quality assurance checks on data collected by the research
assistants who will use a password-protected tablet to
collect data. The data on the tablet will be synchronized
and uploaded in the Open Data Kit (ODK) daily, saved
on a private server, and transferred to a data-analytic
computer program (e.g., SPSS) without the identifying
key. Results will be published regardless of being negative or positive results and submitted to peer-reviewed
scientific journals. A Data Safety Monitoring Committee
(DSMC) will be established specifically for oversight of
the trial and review of serious adverse events and adverse events. The DSMC will include psychiatrists,
non-governmental organization experts in psychosocial
programs, and researchers, and will determine any appropriate action in respect to ongoing trial conduct (e.g.,
referral to specialized care). The DSMC has the right to
unblind at the individual level at any time.
Planned analyses
Qualitative analyses

Focus group discussions (FGDs), key informant interviews, and process evaluation notes will be coded in
NVIVO [35] and analyzed using content analysis [36]
for themes of cultural acceptability, experience of
CPSWs delivering Group PM+, adequacy of training
duration, structure of training, content of training, and
follow-up engagement, following approaches used in
similar global mental health studies [37]. Coding will be
done by multiple independent raters, and inter-rater reliability will be calculated using Kappa scores. Data analysis will be conducted throughout each step to facilitate
iterative revision then finalization of the manual. Following the Consolidated Criteria for Reporting Qualitative
Studies (COREQ), we will document the process according to the 32-item checklist [38]. Broadly, for domain 1
“research team and reflexivity,” the qualitative research
team will include the PIs and TPO staff; the degrees will
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range from MD, PhD, to MA and Bachelors; the occupations will include academic medical faculty, NGO staff,
and members of WHO; there will be both male and female qualitative staff; staff experience in qualitative research will range from 1 month to greater than 10 years;
the relationship with participants will not precede the
study; participants will know that research staff are
employed by or associated with TPO Nepal; and interviewer characteristics (age, education, region of origin,
etc.) will be reported. For study design, content analysis
will be used; selection will be reported as described
above; setting features including location and presence
of non-participants will be reported; an interview guide
will be used; there will be repeat interviews at different
times in the training and supervision timelines; audio
will be recorded; duration will be documented; data saturation or lack thereof will be reported; and transcripts
will not be returned to participants for analysis. There
will be approximately four coders; the coding tree will
be published; themes will be identified in advance with
the option to generate additional themes; participants
will not provide feedback on the coding; quotations will
be presented; data and findings will be consistent; and
major and minor themes will be clearly presented.
Statistical analyses

We will employ statistical analyses comparable to those
used in another pilot c-RCT being conducted in Nepal
[39]. The quantitative outcomes of interest (Table 4) will
be summarized descriptively using appropriate summary
statistics (mean and standard deviation for continuous
outcomes and numbers and proportions for categorical
outcomes) and graphically over time for both study
arms. Trends for each score will be plotted to examine
between- and within-person differences and to determine the plausible pattern (e.g., linearity) of those
trends. As noted by Eldridge et al., there are concerns
that sample size estimates based on this trial’s data could
be too small; therefore, we will also draw upon other
studies in Nepal to inform the subsequent effectiveness
study sample size [40]. We plan to power the full trial
based on conservative estimates of the parameters of
interest rather than exclusively those obtained from this
c-RCT by using the upper bound of the 95% CI for the
intra-class correlation coefficient (ICC) and by comparing our estimates to those from other studies of similar
outcomes to be sure we will increase our estimates if we
find them to be considerably smaller than those from
other studies. By using such a “triangulation” approach
and by obtaining context-specific data, we are confident
that we will be able to better design the full-scale c-RCT
than in the absence of the feasibility c-RCT data. The
data will also be used to inform the choice of effect estimate (e.g., difference in slopes or in means at a specific
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follow-up time point) in the future c-RCT that will build
on the current study. Preliminary indicative estimates of
differences in primary and secondary outcomes by arm
will be obtained. In practice, we will power the future
c-RCT predominantly based on magnitudes of effect that
are of public health relevance rather than using magnitudes of effects obtained from the study, which will not
necessarily be indicative of what could be attained in an
appropriately powered larger c-RCT.
Mixed methods framework

This feasibility study will follow the Good Reporting of
A Mixed Methods Study (GRAMMS) guidelines: First,
mixed methods are being used to evaluate feasibility and
acceptability qualitatively while quantitative information
will be used for the design of the full trial. Second, qualitative and quantitative will be assessed generally during
the same intervals of the study after delivery of Group
PM+. Both methods will be clearly documented in publications with regard to sampling, data collection, and
analysis. Integration will occur in regard to qualitative
descriptions of and quantitative scores on key variables.
Because this is a feasibility study, inference testing on
the quantitative data are limited; therefore, we cannot
compare qualitative and quantitative data with regard to
effectiveness of the Group PM+. Sixth, insights resulting
specifically from integration of qualitative and quantitative will be highlighted.
Ethics and research governance
Consent

The informed consent process will consist of two steps:
informed consent for screening and informed consent
for taking part in the Group PM+ trial. A research assistant will conduct informed consent for screening.
When a possible participant screens positive, the CPSW
will conduct a family session in which potential participants will decide if they would like to take part in Group
PM+. The research assistant will ask the potential participant what family member they would like present for
the consent procedure. Potential participants also have
the option of not including a family member in the consent process. With this model, the participant can gain
support from their family in deciding if they would like
to participate in the trial. In either phase of the consent
process, it will be made clear that refusal to participate
will not have an impact on any type of support they receive and that they will still be referred to local
mhGAP-trained health workers and a counselor if
needed.
Harms

The main risk is potential psychological distress among
participants of the intervention arm depending on the

Sangraula et al. Pilot and Feasibility Studies (2018) 4:126

Page 10 of 13

Table 4 Quantitative outcome measures
Construct

Instrument

Description

Assessment time periods
Enrollment
(−t1)

Baseline
(t0)

Followup (t1)

X

X

Primary outcome (participants)
Depression
symptoms

Patient Health Questionnaire (PHQ-9)

Participants rate depression symptoms over past 2 weeks

Secondary outcomes (participants)
Daily functioning

WHODAS

Participants rate their ability to engage in daily activities

X

X

General
psychological
distress

General Health Questionnaire(GHQ-12)

Participants measure their general psychological distress

X

X

General
psychological
distress

Somatic symptoms of Nepali Psychosocial and
Mental Health Problems (PMHP)

Participants rate their somatic symptoms related to
psychosocial health

General
psychological
distress

Heart-mind

Participants note if they have had any “man ko samasya” or
heart-mind problems recently

General
psychological
distress

Tension Checklist

Participants note if they have had any tension recently

Alcohol use
disorder

Alcohol Use Disorders Identification Test
(AUDIT)

Participants rate alcohol use and associated behavior, as well
as daily ethanol consumption

Post-traumatic
stress symptoms

PTSD Checklist for DSM5 (PCL-5)

Personalized
outcome

Psychological Outcome Profiles (PSYCLOPS)

X

X

X

X

X

X

Participants rate their post-traumatic stress symptoms on a
scale

X

X

Participants list their emotional and practical problems and
rate how much each problem affects them

X

X

X

X

Additional measures of mechanisms and potential mediators
Ways of coping

Reducing Tension Checklist (RTC)

Participants assess their own behavioral and psychosocial skills
related to coping

X

X

Traumatic events

Traumatic Events Inventory (TEI)

Participants rate if they have been exposed to certain
traumatic events throughout their lifetime

X

X

Perceived social
support

Multidimensional Scale of Perceived Social
Support (MSPSS)

Participants assess their own connectedness with close family,
friends, and other forms of support

X

X

Suicidality

Suicidality

Participants rate if they have recently had suicidal thoughts,
ideation, and plans

type of interactions with other group members and group
facilitator. Participants can stop their involvement in the
trial at any point. All patients referred to mhGAP-trained
health workers and TPO counselors are expected to be receiving quality clinical care and management of adverse
events. Primary healthcare workers are supervised by a
psychiatrist in Kathmandu who can provide information
on medications and receive referrals for patients with
worsening symptoms or other clinical concerns.
All changes in treatment resulting from adverse events
or serious adverse events will be reported to the DSMC
in Nepal. TPO Nepal is responsible for the data collection and storage and making data available to the
DSMC, funders, and IRBs for audits when appropriate.
Post-trial care

Group PM+ facilitator training will be provided to those
that attended CPSW basic training in the control arm
after the trial. Though they will not be compensated
through TPO, facilitators in the control arm could deliver Group PM+ sessions post-trial to their community

X

with support from the local government. Primary healthcare workers will remain in the VDC and continue to
provide mental health care for members of the community and Group PM+ trial participants.
Dissemination

Findings from the feasibility study will be published in
academic journals, disseminated through the Mental
Health Innovation Network (www.mhinnovation.net),
and reported to research funder (Office of U.S. Disaster
Foreign Assistance/USAID). Findings will also be disseminated in Nepali and English to key stakeholders including district, provincial, and national government
through reports and presentations. Authorship eligibility
will comply with guidelines of the International Committee of Medical Journal Editors, with additional attention to recommendations for equitable representation of
researchers from LMIC for academic authorship [41]. In
keeping with transparency recommendations, data will
be made publicly available after publication of primary
analyses.
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Timescale

Participants for the Group PM+ trial will be recruited
starting approximately 3 months after the initial CPSW
training (see Table 5 for SPIRIT enrollment and assessment schedule). Group PM+ sessions will begin for
those in the intervention arm within a maximum of
2 weeks after consent. Within these 2 weeks, baseline
will be conducted for both arms. End line will be collected a week to a week and a half after the intervention
is complete in the intervention arm and eight to eight
and a half weeks after initial screening in the control
arm. We anticipate that the trial will conclude by spring
2018.

Discussion
The results of the feasibility trial will be used to determine whether we can move forward with the same procedures for the full trial in another region of Nepal. If
there are qualitative or quantitative indicators of problems with feasibility and acceptability impacting recruitment, retention, randomization, fidelity, or safety, those
Table 5 Schedule of enrollment, interventions, and assessments
for Group PM+
Study period
PARTICIPANTS (direct beneficiaries)—participants of Group PM+ or
control arm
Timepoint

Enrollment

Baseline

Follow-up

− t1

t0

t1

X

Eligibility screen

X

Informed consent

X

Trial status
The trial is open and recruiting as of December 17,
2017. The protocol was last verified 22 January 2018.
Subsequent protocol modifications will be reported to
funders, IRBs, and registered with ClinicalTrials.gov.
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